- Home
- DYAI vs GSIW Comparison
DYAI vs GSIW Comparison
Compare DYAI & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DYAI | GSIW |
|---|---|---|
| Founded | 1979 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.8M | 28.6M |
| IPO Year | 2003 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DYAI | GSIW |
|---|---|---|
| Price | $0.83 | $31.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | 53.0K | ★ 587.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,495,389.00 | N/A |
| Revenue This Year | $12.52 | N/A |
| Revenue Next Year | $92.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 20.58 | N/A |
| 52 Week Low | $0.71 | $0.05 |
| 52 Week High | $1.55 | $9.35 |
Technical Indicators
Market Signals| Indicator | DYAI | GSIW |
|---|---|---|
| Relative Strength Index (RSI) | 50.51 | 94.45 |
| Support Level | $0.73 | $0.11 |
| Resistance Level | $0.84 | N/A |
| Average True Range (ATR) | 0.06 | 2.79 |
| MACD | 0.01 | 3.26 |
| Stochastic Oscillator | 67.30 | 82.76 |
Price Performance
Historical ComparisonAbout DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.